Bowman-Birk inhibitor concentrate

DRUG3 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Healthy, no Evidence of DiseaseLip and Oral Cavity CancerOral LeukoplakiaOropharyngeal CancerTongue CancerUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men

CompletedNCT00287833

National Cancer Institute (NCI)Unspecified Adult Solid Tumor, Protocol Specific

Start: 2006-01-31Target: 20Updated: 2013-05-03

Bowman-Birk Inhibitor Concentrate in Healthy Men

CompletedNCT00679094

National Cancer Institute (NCI)Healthy, no Evidence of Disease

Start: 2007-06-30End: 2009-12-31Updated: 2016-12-29

Phase 2

Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia

CompletedNCT00330382

National Cancer Institute (NCI)Lip and Oral Cavity Cancer, Oral Leukoplakia, Oropharyngeal Cancer +1

Start: 1999-01-31End: 2013-05-31Updated: 2014-12-19